delete National Health (Pharmaceutical Benefits) Regulations (Amendment)
Amendment to the National Health (Pharmaceutical Benefits) Regulations governing the Pharmaceutical Benefits Scheme (PBS), which controls access to subsidized medicines through government-mandated pricing, eligibility criteria, and formulary restrictions.
The PBS represents textbook price control and supply restriction that distort the pharmaceutical market. Government-mandated subsidies and formulary controls create artificial demand patterns, reduce incentives for innovation, and impose compliance burdens on pharmacies and manufacturers. The scheme's copayment structure and listing decisions involve bureaucratic allocation of resources rather than consumer choice. While providing subsidized access to medicines, it does so at the cost of higher overall system costs, reduced competition, and diminished incentives for efficient delivery. Australians would be better served by a system that leverages private insurance and competitive markets to provide affordable access to medicines, allowing individuals to make their own healthcare choices rather than having them made by government committees.